Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Insulin-like Growth Factor-1 to Albumin Ratio as a Biomarker for Sarcopenia Severity in End-Stage Renal Disease Patients on Hemodialysis

NCT07586956 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT07586956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07586956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Insulin-like Growth Factor-1 to Albumin Ratio as a Biomarker for Sarcopenia Severity in End-Stage Renal Disease Patients on Hemodialysis
Lead sponsor
Sohag University
Phase
Observational
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
December 1, 2026
Enrollment
110 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

esrd (end stage renal disease), sarcopenia